March 30 (Reuters) - Advicenne SA ALDVI.PA :
* FY TOTAL REVENUE AND OTHER INCOME EUR 3.0 MLN VS EUR 3.8
MLN YR
AGO
* FY TOTAL GROSS SALES EUR 3.7 MLN VS EUR 3.3 MLN YR AGO
* FY NET LOSS EUR 11.5 MLN VS LOSS EUR 12.4 MLN YR AGO
* END-DEC NET CASH POSITION EUR 8.3 MLN
* OUTLOOK 2023: COMPANY EXPECTS TO ACCELERATE SALES GROWTH
OF
SIBNAYAL, IN EUROPE DIRECTLY AND THROUGH SIGNED PARTNERSHIPS
* OUTLOOK 2023: COMPANY INTENDS TO ENTER NEW COMMERCIAL
AGREEMENTS
IN OTHER GEOGRAPHICAL AREAS
* OUTLOOK 2023: COMPANY WILL PURSUE REGULATORY AND CLINICAL
WORKS
TO BUILD UP POTENTIAL VALUE OF ADV7103 IN DTRA AND IN CYSTINURIA
Source text for Eikon: urn:newsml:reuters.com:*:nNDL3mRCDj
Further company coverage: ALDVI.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))